Hansoh Pharmaceutical issues 108m new shares in recent placing

Hansoh Pharmaceutical Group Company Limited reported its monthly return for the period ended August 31, 2025, revealing an increase of 108,000,000 ordinary shares in its issued share capital. This brings the total number of issued shares (excluding treasury shares) to 6,055,150,070, up from 5,947,150,070 at the close of the preceding month. The company's total authorized/registered share capital remains at HK$200,000, representing 20,000,000,000 ordinary shares with a par value of HK$0.00001 per share.

The increase stems from a placing and subscription of new shares, with 108,000,000 new ordinary shares issued at a price of HK$36.3 per share on August 27, 2025. This transaction was conducted under a general mandate approved on June 20, 2025.

Additionally, the company has zero coupon convertible bonds due 2026, issued on January 22, 2021, with an amount of $5,378,000 and a subscription/conversion price of HK$57.48. As of the close of the month, 725,384 shares may be issued pursuant to these convertibles. There were no movements in treasury shares during the month.